STO-609 acetate
CAS No. 1173022-21-3
STO-609 acetate ( —— )
Catalog No. M17166 CAS No. 1173022-21-3
STO-609 acetate is selective, cell-permeable inhibitor of Ca2+-calmodulin-dependent protein kinase kinase (Ki: 80/15 ng/ml, for CaM-KKα/KKβ); competes for the ATP-binding site.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 50 | In Stock |
|
5MG | 83 | In Stock |
|
10MG | 153 | In Stock |
|
25MG | 243 | In Stock |
|
50MG | 380 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSTO-609 acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSTO-609 acetate is selective, cell-permeable inhibitor of Ca2+-calmodulin-dependent protein kinase kinase (Ki: 80/15 ng/ml, for CaM-KKα/KKβ); competes for the ATP-binding site.
-
DescriptionSTO-609 acetate is selective, cell-permeable inhibitor of Ca2+-calmodulin-dependent protein kinase kinase (Ki: 80/15 ng/ml, for CaM-KKα/KKβ); competes for the ATP-binding site. It displays > 80-fold selectivity over CaMK1/2/4, PKC, MLCK, PKA and p42 MAPK.
-
Synonyms——
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorCaM-KKα; CaM-KKβ
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number1173022-21-3
-
Formula Weight374.35
-
Molecular FormulaC19H10N2O3·C2H4O2
-
Purity98%
-
Solubility——
-
SMILESCC(=O)O.c1ccc2c(c1)nc1n2c(=O)c2cccc3c(ccc1c23)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tokumitsu H, et al. J Biol Chem. 2002 May 3;277(18):15813-8.
molnova catalog
related products
-
2-Aminobenzenesulfon...
2-Aminobenzenesulfonamide is a molecule containing the sulfonamide functional group attached to an aniline.
-
Ginkgolide K
Ginkgolide K induces protective autophagy through the AMPK/mTOR/ULK1 signalling pathway. It possesses neuroprotective activity.
-
AUTEN-67
A small molecule autophagy enhancer that specificly inhibits myotubularin-related phosphatase MTMR14; at concentrations of 2, 10, and 100 uM, AUTEN-67 inhibits MTMR14 by nearly 3%, 25%, and 70%, respectively.